Assisting Social Security Disability Insurance Beneficiaries With Schizophrenia, Bipolar Disorder, or Major Depression in Returning to Work

Department of Psychiatry, University of Maryland, Baltimore, Baltimore, Maryland, United States
American Journal of Psychiatry (Impact Factor: 12.3). 08/2013; 170(12). DOI: 10.1176/appi.ajp.2013.13020214
Source: PubMed


People with psychiatric impairments (primarily schizophrenia or a mood disorder) are the largest and fastest-growing group of Social Security Disability Insurance (SSDI) beneficiaries. The authors investigated whether evidence-based supported employment and mental health treatments can improve vocational and mental health recovery for this population.

Using a randomized controlled trial design, the authors tested a multifaceted intervention: team-based supported employment, systematic medication management, and other behavioral health services, along with elimination of barriers by providing complete health insurance coverage (with no out-of-pocket expenses) and suspending disability reviews. The control group received usual services. Paid employment was the primary outcome measure, and overall mental health and quality of life were secondary outcome measures.

Overall, 2,059 SSDI beneficiaries with schizophrenia, bipolar disorder, or depression in 23 cities participated in the 2-year intervention. The teams implemented the intervention package with acceptable fidelity. The intervention group experienced more paid employment (60.3% compared with 40.2%) and reported better mental health and quality of life than the control group.

Implementation of the complex intervention in routine mental health treatment settings was feasible, and the intervention was effective in assisting individuals disabled by schizophrenia or depression to return to work and improve their mental health and quality of life.

84 Reads
  • Source
    • "In particular, high rates of risky sexual behaviors (Dickerson et al., 2004) and intravenous drug use (Carey et al., 2004) contribute to increased prevalence of HIV in this group (Rosenberg et al., 2001). The high burden of somatic conditions in this population leads to costly disability: persons with SMI are the largest and fastest growing subgroup of social security disability beneficiaries in the US (Drake et al., 2013; Substance Abuse and Mental Health Administration (SAMHSA), 2010). Poor health and disability outcomes in the population with SMI are affected by multiple factors, including severity and complexity of comorbid conditions (Jones et al., 2004), individual health behaviors (Compton et al., 2006; Daumit et al., 2005; Henderson et al., 2006), socioeconomic status (Mueser and McGurk, 2004), neighborhood and living conditions that may facilitate or impede adoption of healthy behaviors or access to services (Chun-Chung, 2003), and – the focus of this review – quality of medical care. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prior studies suggest variation in the quality of medical care for somatic conditions such as cardiovascular disease and diabetes provided to persons with SMI, but to date no comprehensive review of the literature has been conducted. The goals of this review were to summarize the prior research on quality of medical care for the United States population with SMI; identify potential sources of variation in quality of care; and identify priorities for future research. Peer-reviewed studies were identified by searching four major research databases and subsequent reference searches of retrieved articles. All studies assessing quality of care for cardiovascular disease, diabetes, dyslipidemia, and HIV/AIDs among persons with schizophrenia and bipolar disorder published between January 2000 and December 2013 were included. Quality indicators and information about the study population and setting were abstracted by two trained reviewers. Quality of medical care in the population with SMI varied by study population, time period, and setting. Rates of guideline-concordant care tended to be higher among veterans and lower among Medicaid beneficiaries. In many study samples with SMI, rates of guideline adherence were considerably lower than estimated rates for the overall US population. Future research should identify and address modifiable provider, insurer, and delivery system factors that contribute to poor quality of medical care among persons with SMI and examine whether adherence to clinical guidelines leads to improved health and disability outcomes in this vulnerable group. Copyright © 2015 Elsevier B.V. All rights reserved.
    Schizophrenia Research 04/2015; 165(2-3). DOI:10.1016/j.schres.2015.04.010 · 3.92 Impact Factor
  • Source
    • "People who are older, disabled, poorer, or less educated are less likely to have Internet access or a smartphone. This is of concern since many patients with bipolar disorder are unemployed or disabled (Marwaha et al. 2013; Drake et al. 2013). Currently, paper handouts are still recommended for information that should be read by all patients with bipolar disorder. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adults routinely use the Internet as a source of health information. Patients with bipolar disorder and caregivers should be encouraged to increase their knowledge of this complex illness, including through the Internet. However, patients, caregivers, and physicians should be aware of potential perils when searching the Internet for health information, including loss of privacy, quality of web site content, and Internet scams. This review summarizes these cautionary issues. The digital divide remains and includes a lack of technical skills and competency in searching and appraising web sites, in addition to limited access to the Internet. Physicians should provide patients with a list of trustworthy web sites and a brief printed handout on concerns related to searching the Internet. More studies of the use of the Internet by patients with bipolar disorder are needed.
    10/2013; 1(1). DOI:10.1186/2194-7511-1-22
  • Source
    American Journal of Psychiatry 12/2013; 170(12):1379-81. DOI:10.1176/appi.ajp.2013.13091176 · 12.30 Impact Factor
Show more


84 Reads
Available from